Skip to content
healthcare.dev

Karbinal ER

NDC 23594-101, Carbinoxamine Maleate, suspension, extended release, from Aytu Therapeutics, LLC.

Product NDC
23594-101
Status
Listed
Labeler
Aytu Therapeutics, LLC
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022556
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/23594-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE4 mg/5mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
23594-101-01235940101012 BOTTLE, PLASTIC in 1 CARTON (23594-101-01) / 30 mL in 1 BOTTLE, PLASTIC
23594-101-0523594010105480 mL in 1 BOTTLE, PLASTIC (23594-101-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c40b3f4e-2d71-41a1-a1fc-f64f38724879
  • NADAC price for package 23594010105

    GET /v1/drugs/nadac/23594010105

Use it

Look up 23594-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/23594-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 23594-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.